FIT was founded in 2015 to develop and commercialize SESI and IMS systems to expand the applicability of mass spectrometry in the clinical arena. As a Spin-out of a research group, we are well aware of the challenges faced by scientists today.
We are experts in SESI ionization. Since 2008, we have accumulated several years of experience in the development of industrial, security, and biomedical applications of SESI for research purposes. In 2014 and 2015, we joined the project ACID (Marie Curie) at ETH-Zurich and developed the Low Flow SESI source, which provided record ionization efficiency, enabling previously impossible studies. We have further improved performance and usability to bring SESI-MS analysis and breath research to the scientific community.
SUPER SESI is the result of the last two years of research and product development, and several years of previous research. Our goal is to serve the breath research community, so that large metabolites with low volatility can be routinely detected and analyzed in real time.